Manuel Almela

51 papers receiving 3.3k citations

Hit Papers

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial 1990 · 443 citations
4431988202620002013100200300400500

Peers

Manuel Almela
Comparison fields: 5 of 113
  • Applied Microbiology and Biotechnology 420
  • Molecular Medicine 755
  • Critical Care and Intensive Care Medicine 723
  • Epidemiology 2.2k
  • Hepatology 461
Replace Michele Bartoletti with:
Michele Bartoletti Italy
Núria Sabé Spain
José Mensa Spain
M. T. Jiménez de Anta Spain
Hsin‐Yun Sun Taiwan
Sara Tedeschi Italy
José Sifuentes‐Osornio Mexico
Stephanie H. Factor United States
Francesco Cristini Italy
Leanne B. Gasink United States
Manuel Almela relative to Michele Bartoletti Italy Michele Bartoletti's profile →
Citations per field
00.5×3.0×
Michele Bartoletti · 1×
Citations per year

Countries citing papers authored by Manuel Almela

Since Specialization
Citations

This map shows the geographic impact of Manuel Almela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Almela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Almela more than expected).

Fields of papers citing papers by Manuel Almela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Almela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Almela. The network helps show where Manuel Almela may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manuel Almela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Almela Line = papers co-authored together Manuel Almela links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201918
2 201810
3 201540
4 201518
5 201313
6 201331
7 201178
8 200926
9 2009144
10 200912
11
Bacteriemia por Staphylococcus aureus resistente a meticilina. Factores asociados al aislamiento de cepas con concentración mínima inhibitoria de vancomicina > 2 mg/L
20082
12 200721
13 200633
14 2005484
15 200427
16 2003264
17 20007
18 2000137
19 199117
20 198915

About Manuel Almela

Manuel Almela is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Biotechnology and Infectious Diseases, having authored 51 papers that have together received 3.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Listeria monocytogenes in Food Safety (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Streptococcal Infections and Treatments (6 papers), Pneumonia and Respiratory Infections (6 papers), Infective Endocarditis Diagnosis and Management (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (420 citations), Molecular Medicine (755 citations), Critical Care and Intensive Care Medicine (723 citations), Epidemiology (2.2k citations) and Hepatology (461 citations). Manuel Almela has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Francesc Marco, Antoní Torres, Josep M. Gatell, Robert Rodriguez-Roisín, Rosa Celis, Àlex Soriano, José Mensa, Benito Almirante, M. T. Jiménez de Anta and Josep Mensa. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Journal of Clinical Microbiology, The Journal of Infectious Diseases and Journal of Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026